AO Spine Research Top 10 - No. 7 - Novel Therapies - a podcast by AO Spine Research Top 10 from Myelopathy Matters
from 2020-11-29T06:00:22
Novel therapies for DCM are the No. 7 priority explored by Michelle and Ben. Ricardo Rodrigues-Pinto outlines our current limitations and the potential spectrum of advances, from biological treatments to assistive technologies. Annie Wandycz shares her lived experience of therapies for DCM, her frustrations and optimism, and her helpful perspectives from the online support group. Mark Kotter explains how novel experimental treatment paradigms can deliver progress in both laboratory and clinical settings, and Julio Furlan describes how strategies for neurorehabilitation in spinal cord injury could advance the DCM field.
Further episodes of Myelopathy Matters
Further podcasts by AO Spine Research Top 10 from Myelopathy Matters